Health News Releases

  • Today April 22
July 22, 2022 09:40
DentalMonitoring: July Product Announcements
DentalMonitoring has launched a breakthrough service for dental professionals and industry partners: the DM Intelligent Platform is now the only digital workflow which can interface and integrate with
July 21, 2022 16:20
Biocytogen and LiberoThera Achieve Milestone Progress in Co-Development of Fully Human GPCR Antibody Drugs
February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) entered a strategic collaboration with LiberoThera Co., Ltd (“LiberoThera”) to co-develop fully human GPCR antibodies u
July 21, 2022 14:30
Randomized Controlled Study Finds Masimo SedLine® Brain Function Monitoring Can Help Guide Anesthesia in Children Undergoing Minor Surgery
Masimo (NASDAQ: MASI) today announced the findings of a randomized, controlled trial published in the Journal of Clinical Anesthesia in which Dr. Melody H.Y. Long and colleagues from the KK Women’s an
July 21, 2022 09:40
STALICLA Awarded EUR 1.7 Million to Lead Computational Drug Repositioning Activities in EU-funded REPO4EU Project
REPO4EU consortium seeks to address the urgent need for new cost-effective therapies, as well as to improve existing treatments through international cooperation, pooling research and innovation exper
July 20, 2022 14:00
Prestigous West Coast Academic Medical Center Renews Six-Figure, Multi-Year Agreement For Privacy And Security Managed Services
CynergisTek, Inc. (NYSE American: CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issue
July 20, 2022 10:30
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that a phase III clinical trial for SINOVAC’s inactivated quadriva
July 20, 2022 09:05
Pharma Proposes to Work with G7 and G20 on a Joint Solution for Better Access to Vaccines and Treatments Around the World for Future Pandemics
The biopharmaceutical industry launched today the “Berlin Declaration - biopharmaceutical industry vision for equitable access in pandemics” and presents global leaders with a proposal that could help
July 19, 2022 19:00
Covac Global Redefines Duty of Care With No Hospitalization Requirement for Repatriation and Newly-added Coverage for Monkeypox
Covac Global, the Premier Medical Evacuation Membership, pioneered the simple approach to medical evacuation with “Get Sick, Get Home” requiring no hospitalization, announces it will include repatriat
July 19, 2022 14:21
Peoplecare Chooses Boomi and Atturra To Connect Member Data For Personalized Health Fund Experiences
Boomi™, the intelligent connectivity and automation leader, today announced that Peoplecare, an Australian health insurance mutual fund, implemented The Boomi AtomSphere™ Platform to deliver improved
July 18, 2022 21:15
Q2 Update by PQE Group: Two Acquisitions’ Announcements With United Pharma Technologies Inc. & Quintian Pharma, and New Two Offices
The first half of 2022 has closed highly positively for PQE Group, the global women-owned quality consulting company for Lifesciences. The Italian parent Group, after having concluded 2021 with + 20%
July 18, 2022 16:11
Growing Prevalence of Bleeding Disorders and Advancements in Treatments to Bolster Market Revenue; Reaching USD 19.9 Bn: Report Fact.MR
As per an in-depth industry analysis on bleeding disorders treatment by Fact.MR, market research and competitive intelligence provider, the global market is anticipated to expand at a CAGR of 6.7% ove
July 15, 2022 11:00
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its COVID-19 vaccine (CoronaVac) has been approved by the Bra
July 13, 2022 16:45
Extension of the postponement of the settlement of Vifor Pharma tender offer
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Limited (ASX: CSL; USOTC:CSLLY) today announced an update regarding the Vifor Pharma AG acquisition. On January 18, 2022, CSL B
July 13, 2022 11:30
Fluke Biomedical OneQA Now Supports Patient Monitor Testing
Fluke Biomedical announced the OneQA test and workflow automation software now supports the top-selling ProSim 8 multifunction patient simulator. Fluke Biomedical OneQA is an industry-leading quality
July 13, 2022 10:10
Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim
The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record
July 12, 2022 10:15
Takeda Announces the Submission of its Corporate Governance Report to the Tokyo Stock Exchange
Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502/NYSE:TAK) today announced that it has filed its Corporate Governance Report with the Tokyo Stock Exchange (“TSE”) in accordance with the re
July 12, 2022 09:24
Why Oral Care is Receiving the Most Support Among Different Types of Dental Laboratories; Sales To Top With USD 5.3 Bn by 2032: Latest Study by Fact.MR
The dental laboratories market revenues were estimated at USD 29.6 Bn in 2021 and are anticipated to grow at a CAGR of 5.6% from 2022-2032, according to a recently published Fact.MR report. By the
July 08, 2022 14:10
New Study shows Urolithin A (Mitopure®) Improves Mitochondrial Health, Reduces Joint Cartilage Damage and Alleviates Pain in Osteoarthritis
Amazentis, a spin-off of the Swiss Federal Institute of Technology (EPFL) pioneering scientific breakthroughs in cellular health and nutrition, announced today that the peer-reviewed journal Aging Cel
July 07, 2022 10:10
KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland
KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, held a joint ribbon-cutting ceremony yesterday at their new state-of-the-art facility in Geneva, Switzerland. Designed to direc
July 07, 2022 09:20
Growing Applications In Clinical Research Activities Have Significant Importance In Developments Of Healthcare Automation Market With Anticipation Of USD 88.9 Bn: Fact.MR
Fact.MR, a market research and competitive intelligence provider, has conducted a comprehensive analysis of the healthcare automation market, which is expected to rise at a CAGR of 8.4% over the forec
July 06, 2022 16:15
Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, the life science company Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and bioMérie
July 06, 2022 13:20
Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx
The collaboration combines Aurigene’s small molecule drug discovery platform and EQRx's pioneering business model to accelerate the development of drug candidates in the areas of oncology and immune-i
(above) Vial filling station at Vetter’s Rankweil site/(below) Area for material preparation at Vett
July 05, 2022 13:25
Vetter’s Newest Clinical Manufacturing Site Successfully Completed its First Customer Fills
With the realization of the first successful customer fills, Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has reached another milestone at its new clinical manu
July 05, 2022 11:40
SINOVAC joins hands with HKU-CTC research team and Gleneagles Hospital Hong Kong to kick off a clinical trial of an Omicron-specific inactivated vaccine for booster use in Hong Kong, China
A kick off ceremony was held at Gleneagles Hospital Hong Kong (Gleneagles or GHK) for initiating a clinical trial to assess the safety and immunogenicity of the SINOVAC’s Omicron-specific COVID-19 ina
July 01, 2022 15:19
Takeda’s TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE Attacks in First and Only Open-Label Phase 3 Trial in Children Ages 2 to <12 Years
Takeda (TSE:4502/NYSE:TAK) today announced late-breaking data from the Phase 3 SPRING study (NCT04070326) presented at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2
25 per page50 per page75 per page100 per page